By admin
Moderna, a biotech company specializing in messenger RNA (mRNA) therapeutics and vaccines, announced that its manufacturing facility in Mississauga, Ontario, Canada, has received a Drug Establishment License (DEL) from Health Canada. The DEL allows Moderna to manufacture and distribute its COVID-19 vaccine, Spikevax, in Canada.